Press Releases

Press Releases

September 23, 2020
SAN DIEGO , Sept. 23, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, is proud to announce the addition of Ms. Wendy S. Johnson as an additional independent member to its Board of
July 30, 2020
SAN DIEGO , July 30, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced that Ron Rocca , President and Chief Executive Officer of Exagen , will present at the Canaccord
July 28, 2020
Testing Experiencing Monthly Sequential Improvement Record Gross Margins of 63% SAN DIEGO , July 28, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today reported financial results for
July 27, 2020
AVISE Tests Now Available to 6 Million Humana Military Beneficiaries SAN DIEGO , July 27, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced that all AVISE test offerings
Displaying 1 - 10 of 22